Table 3 Summary of methodological quality assessment scores
References | Impellizzeri et al. (2008) [24] | Zago et al. (2016) [25] | Cè et al. (2018) [26] | Tarakci, Pinar (2021) [27] | Eniseler et al. (2017) [28] | Özcan, Şahan (2018) [29] | Zois et al. (2013) [30] | Burcak (2015) [31] | Kaya et al. (2021) [32] | Cuong Le et al. (2023) [33] | Smith et al. (2016) [34] |
|---|---|---|---|---|---|---|---|---|---|---|---|
Eligibility criteria | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 1 | 1 | 1 |
Random allocation | 1 | 1 | 1 | 0 | 1 | 1 | 1 | 0 | 1 | 0 | 1 |
Allocation Concealment | 1 | 1 | 1 | 0 | 1 | 1 | 1 | 0 | 1 | 0 | 1 |
Baseline Comparability | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Blind Participants | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
Blind Therapist | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Blind Assessor | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
Follow-up | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Intention to Treat Analysis | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Between Group Comparisons | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 1 |
Point Measure and Variability | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Total PEDro Score | 7 | 6 | 6 | 4 | 6 | 6 | 6 | 4 | 6 | 3 | 8 |
References | Smith et al. (2017) [35] | Greco et al. (2017) [36] | Filipas et al. (2021) [37] | Bian et al. (2022) [18] | Lyons et al. (2006) [38] | Rampinini et al. (2008) [39] | Draganidis et al. (2013) [40] | Lyons et al. (2021) [41] | Ali et al. (2011) [42] | Owen et al. (2013) [43] | Ali et al. (2007) [44] |
Eligibility criteria | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Random allocation | 1 | 1 | 1 | 1 | 0 | 0 | 1 | 0 | 1 | 1 | 1 |
Allocation Concealment | 1 | 1 | 1 | 1 | 0 | 0 | 1 | 0 | 1 | 1 | 1 |
Baseline Comparability | 1 | 1 | 0 | 1 | 1 | 1 | 1 | 0 | 1 | 1 | 1 |
Blind Participants | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Blind Therapist | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Blind Assessor | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Follow-up | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Intention to Treat Analysis | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Between Group Comparisons | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Point Measure and Variability | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Total PEDro Score | 7 | 6 | 7 | 6 | 4 | 4 | 6 | 3 | 6 | 6 | 6 |
References | Ali, William (2009) [45] | Foskett et al. (2009) [46] | Gant et al. (2010) [47] | O'Reilly, Wong (2013) [48] | Andrade-Souza et al. (2015) [49] | Shabir et al. (2019) [50] | Barte et al. (2019) [51] | Khalifa et al. (2020) [52] | O’Meagher et al. (2022) [53] | Vansteenkiste et al. (2022) [51] | Halabchi et al. (2017) [55] |
Eligibility criteria | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Random allocation | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 1 |
Allocation Concealment | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 1 |
Baseline Comparability | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 1 | 1 | 0 | 1 |
Blind Participants | 1 | 1 | 1 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 1 |
Blind Therapist | 1 | 1 | 1 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 1 |
Blind Assessor | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Follow-up | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Intention to Treat Analysis | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Between Group Comparisons | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Point Measure and Variability | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Total PEDro Score | 9 | 8 | 8 | 6 | 8 | 8 | 5 | 6 | 4 | 3 | 8 |